- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
APP changes name to Radiologix
American Physician Partners has changed its name, effective Sept. 24, to Radiologix. The Dallas company’s stock symbol changed from APPM to RDLX three days later, and continues to trade on the Nasdaq exchange. The move comes just weeks after the
American Physician Partners has changed its name, effective Sept. 24, to Radiologix. The Dallas companys stock symbol changed from APPM to RDLX three days later, and continues to trade on the Nasdaq exchange. The move comes just weeks after the company acquired imaging center operator Questar Imaging in a deal valued at $44.6 million (SCAN 8/18/99). The Questar deal made Radiologix one of the largest operators of radiology centers in the U.S.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
